Inventor · disambiguated record
Steven H. Spergel
Also filed as: SPERGEL STEVEN H
40 granted patents·12 pending applications·600 citations·filing 1990–2024
98Inventor score
Top patents by PatentIndex Score
52 records- 0198US11866414B2Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Jan 9, 2024·11 cites·23 claims
- 0297US9505748B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 29, 2016·53 cites·9 claims
- 0396US10000480B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 19, 2018·20 cites·14 claims
- 0496US6706717B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 16, 2004·73 cites·11 claims
- 0595US11767322B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 26, 2023·3 cites·66 claims
- 0695US7683171B21H-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 23, 2010·46 cites·9 claims
- 0794USRE47929EAmide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 7, 2020·19 cites·39 claims
- 0893US10913738B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 9, 2021·7 cites·14 claims
- 0993US7241781B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jul 10, 2007·17 cites·16 claims
- 1093US5846990ASubstituted biphenyl isoxazole sulfonamidesBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Dec 8, 1998·132 cites·31 claims
- 1192US6635626B1Imidazoquinoxaline protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Oct 21, 2003·55 cites·16 claims
- 1292US5481011AProcess for preparing N-protected amino acid α-halomethyl ketones and alcohols from N-protected amino acid estersBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jan 2, 1996·45 cites·16 claims
- 1390US7141578B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 28, 2006·17 cites·14 claims
- 1489US8354398B2Substituted isoxazole compoundsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jan 15, 2013·13 cites·12 claims
- 1587US2025243193A1Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1686US8404672B2Substituted heterocyclic compoundsPITTS WILLIAM J·Filed 2010·Granted Mar 26, 2013·13 cites·12 claims
- 1784US5202486ATetrahydroethanonaphthaleneamine derivativesSQUIBB & SONS INC·Filed 1990·Granted Apr 13, 1993·23 cites·8 claims
- 1883US6239133B1Imidazoquinoxaline protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted May 29, 2001·12 cites·18 claims
- 1982US7517904B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Apr 14, 2009·1 cites·3 claims
- 2082US2025163004A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2181US11440913B2Aminoimidazopyridazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 13, 2022·2 cites·14 claims
- 2281US7456194B2Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 25, 2008·5 cites·6 claims
- 2380US7737279B21,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 15, 2010·4 cites·8 claims
- 2479US12110290B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 2579US2025074909A1Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2679US2024190829A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2778US2024425505A1Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2876US2022356180A1Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2975US11884650B2Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Jan 30, 2024·0 cites·6 claims
- 3075US2024124421A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3174US7655689B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Feb 2, 2010·1 cites·13 claims
- 3274US7557211B28H-imidazo[4,5-D]thiazolo[4,5-B]pyridine based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jul 7, 2009·2 cites·6 claims
- 3370US8987268B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Mar 24, 2015·2 cites·14 claims
- 3469US6958336B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 25, 2005·2 cites·17 claims
- 3569US6956045B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 18, 2005·2 cites·17 claims
- 3669US6953795B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 11, 2005·2 cites·17 claims
- 3767US12157733B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 3, 2024·0 cites·6 claims
- 3867US7176214B2Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 13, 2007·3 cites·20 claims
- 3967US5492910ARetrocarbamate protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Feb 20, 1996·9 cites·10 claims
- 4066US7037926B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 2, 2006·1 cites·17 claims
- 4164US9221826B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Dec 29, 2015·1 cites·10 claims
- 4260US2024270723A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 4360US2024317718A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 4459US2025066322A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 4556US5276026ATetrahydroethanonaphthaleneamine derivativesSQUIBB & SONS INC·Filed 1993·Granted Jan 4, 1994·4 cites·5 claims
- 4654US2006217412A1Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising samePITTS WILLIAM J·Filed 2006·Application pending·0 cites
- 4751US12240840B2Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alphaBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 4, 2025·0 cites·2 claims
- 4851US2004077605A1Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionFiled 2002·Application pending·0 cites
- 4949US11299494B2Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-α modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 12, 2022·0 cites·20 claims
- 5046US10836770B2Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 17, 2020·0 cites·16 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →